Increasing Access to Injection Equipment in Burkina Faso: When Essential Drugs Programmes Improve Injection Safety Sophie Logez Phamaciens Sans Frontières.

Slides:



Advertisements
Similar presentations
India Injection Safety Coalition. If you have an apple and I have an apple and we exchange these apples then you and I will still each have one apple.
Advertisements

Could the WHO Model List of Essential Medicines do more for the Rational and Safe Use of Injections? Logez S, Hutin Y, Holloway K, Robin G, Hogerzeil H.
Medication Management
10/07/02 Waste Management Planning Process in St Louis - Sénégal P. Jaillard, AMP, CVP/PATH SIGN Meeting, Phnom Penh.
Safety Guidelines Illness and Injury Prevention Safety Guidelines Illness and Injury Prevention 2.01 Understand safety procedures 1.
World Health Organization
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Managing Sharps Waste In Cambodia SIGN Meeting, 25 October 2002 Cambodiana Hotel, Phnom Penh Dr. Chea Kim Ly, Deputy Director National Immunization Program.
Towards Curative Auto- Disable Syringes Dr Yvan Hutin Department of Blood Safety and Clinical Technology WHO, Geneva.
THE IRRATIONAL USE OF DRUGS IN RURAL CHINA: EVIDENCES FROM TWO PROVINCES Qiang SUN, Jia YIN, Genyong ZUO, Qingyue MENG Center for Health Management & Policy,
Injection Safety in EPI: More than just AD Syringes and Safety Boxes World Health Organization HTP/V&B/EPI.
Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.
Injection Practices in Mongolia Results and Outcomes of the Rapid Assessment of Injection Practices Dr G. Soyolgerel Dr G. Soyolgerel Ministry of Health.
NATIONAL EVALUATION OF MEDICINES DISPENSING WITHIN BRAZILIAN AIDS PROGRAM Third International Conference for Improving Use of Medicines Azeredo TB, Luiza.
WHO Health Care Waste Management Protection of the Human Environment (PHE) Richard M. Carr.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Synergy and Partnership for Injection Safety: the Senegal experience Jules Millogo, MD, MSc Immunization Advisor BASICS II A USAID-financed project administered.
By Denis Kaffoko,(MSC.DE,B.STAT,PCGME) The effect of Scale up of TB-DOTS Services on Case Detections and Treatment success rates in Central Uganda.
Sol-Millennium MVP Injection Solution Contributor to Safety Injection In Immunization Service.
WHO Health Care Waste Management Protection of the Human Environment (PHE) Richard M. Carr.
Plan of Action to improve injection Safety Within the EPI.
The WHO injection safety assessment tool: first results SIGN Meeting 2001 New Delhi, India.
SIGN Rapid Assessment Survey Northern Areas, Pakistan Lubna Samad, MRCS, FCPS Pediatric Surgeon National Institute of Child Health.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Countries Experiences on Access to Injection Equipment Sophie Logez WHO/BCT/DCT Phnom Penh, October 2002.
EVALUATION OF A SAFE INJECTION PROJECT IN UZBEKISTAN Dr. Erkin I. Musabaev Institute of Postgraduate Medical Education, Tashkent Uzbekistan Health Ministry.
Treatment of drug addiction in prisons
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
Indonesia country office Household and health facility surveys in Indonesia Indonesia country team Jakarta, Indonesia.
1 Dr.I.A.Joshua 2 Dr JG Makama 3 Dr A Oyemecho 1 Department of Community/ 2 Department of Surgery Kaduna State University, Kaduna, Nigeria 3 Department.
Using Longitudinal Data for Evaluating Policy Changes and Other Interventions -Information system in Tamilnadu Medical Services Corporation.
Safe Immunization Practices and Prevention of Hepatitis B and C Susan Mackay Behaviour Change Project Safe Injection Global Network.
GAVI/Vaccine Fund Support to Improve Injection Safety On behalf of the Injection Safety sub-group.
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa 2, 1 Ministry of Health, 2 Pharmacy School, Health.
Development of Injection Safety Assessment Toolbox Rebecca Fields The CHANGE Project/USAID.
ACCESS TO MEDICINES - POLICY AND ISSUES
BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Promoting Drug and Therapeutics Committees in the Developing World
A BASELINE SURVEY OF THE PHARMACEUTICAL SECTOR IN TANZANIA
Abstract Impact of the Essential Drugs Programme at the Primary Health Care Level in South Africa Hela M, Zeeman H, Department of Health South Africa;
Public Perceptions about Injections and Private Sector Injection Practices in Central Nepal Mahesh Bhattarai and Scott Wittet.
Injection Safety: Updates from Michigan and the U.S. October 9, 2015 Emily Goerge, MPH, MSN, RN, CIC.
Authors: Lates JA, Shiyandja NN Funding Institution: Ministry of Health and Social Services, Namibia Title: Third National Survey on the Use of Drugs in.
MONITORING MEDICINE AVAILABILITY AND PRICES IN UGANDA By Denis Kibira HEPS Uganda.
A Pilot Intervention To Improve Injection Practices In The Informal Private Sector in Karachi, Pakistan Mubina Agboatwalla (1) Yvan Hutin (2) Steve Luby.
WHO PRESCRIBING INDICATORS (1991 – 1995) TRENDS AND PERSPECTIVES IN AN OUTPATIENT HEALTH CARE FACILITY IN BENIN CITY, NIGERIA. 1 Isah AO, 2 Isah EC, 3.
Improvement of Injection Safety in Burkina Faso, JF. Aguilera, J. Fitzner, A. Yaméogo, Y. Hutin.
A media campaign to promote safe immunization injections in Tanzania (This presentation was modified from its original layout. It has been adapted for.
Vaccines & Biologicals (V&B) Cost-effectiveness of safe injection policies: Study rationale and proposed methodology Ulla Kou, WHO SIGN meeting in New.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
Promoting Rational Drug Use in the Community Prioritising Community Drug Use Problems.
Documenting (Driving) Progress in Immunization Injection Safety Philippe Duclos, WHO Presented at the SIGN annual meeting, Cairo, Egypt, Oct th,
ICIUM 2004-CHIANG MAI SURVEY REPORT ON RATIONAL USE OF DRUGS In 30 Primary Health Centres of Tamilnadu, India.
Abstract Problem Statement: As in many former socialist economies, anecdotal reports suggested that injections were overused to administer medications.
ABSTRACT THE IMPACT OF CONTINUOUS MEDICAL EDUCATION ON PRESCRIBING HABITS IN MISSION HOSPITALS IN KENYA By John Kiambuthi Mission for essential drugs and.
Impact of Currency Crisis on Availability, Affordability, and Use of Medicines in Indonesia: A 5-Year Longitudinal Study Sri Suryawati Center for Clinical.
Impact of the Tamilnadu Medical Services Corporation on Drug Prescribing in primary Health Care Murali R,Sathyanarayanan D,Rajkumar C,Senthil Kumar R,Usha.
New WHO Guidelines on Person centred monitoring
Logez S, Hutin Y, Somda P, Thualt J, Holloway K
ABSTRACT THE IMPACT OF CONTINUOUS MEDICAL EDUCATION ON PRESCRIBING
SUNARTONO HEAD OF SLEMAN DISTRICT HEALTH OFFICE, INDONESIA
Addressing Drug Use Together Through a Health Based Approach:
Controlling Measuring Quality of Patient Care
Safety Guidelines Illness and Injury Prevention
Health Technology Assessment for Universal Health Coverage
Toktobaeva B, Karymbaeva S Drug Information Centre Kyrgyzstan
Safety Guidelines Illness and Injury Prevention
Safety Guidelines Illness and Injury Prevention
Presentation transcript:

Increasing Access to Injection Equipment in Burkina Faso: When Essential Drugs Programmes Improve Injection Safety Sophie Logez Phamaciens Sans Frontières Clermont Ferrand, France

Objectives of the Study (2000 & 2001) Evaluate the impact of national drug policy on injection safety between 1992 and 2001, including: –Describing the features of the national drug policy that may have influenced injection practices –Quantifying the changes in access to injection equipment –Quantifying the changes in injection practices –Identifying the potential adverse effects of National Drug Policy on: Injection overuse Sharps waste management

Methodology Cross-sectional study : –Phase 1: Injection practices, Aguilera and Fitzner(2000) –Phase 2: National drug policy evaluation, Logez (2001) Two-stage cluster sampling –8 districts, probability of selection proportional to population size –10 health centres in each districts, simple random sampling Data Collection Procedure (Phase 2) –Interviews with key stakeholders (Centre level) –Interviews with district wholesalers (District level) –Review of registers, Interviews with healthcare workers, pharmacy staff, and the population ( Healthcare centre level)

* * Re-use of equipment exceeded 50% in 1995

Key Elements of the National Drug Policy Central level –National drug policy formulation with regulatory framework –Central bulk procurement by public-private consortium –Injection equipment in National Essential Drug List, with set price District level –Wholesalers and supervisory team Healthcare centre level –Community pharmacies in each healthcare centre –Cost recovery according to the Bamako initiative, including for routine EPI injection equipment

Increased Access to Injection Equipment 5 ml Syringes sale in Burkina Faso –1996: –2000: Price of new 5 ml disposable syringes and needle sets –10 US cents Price of equipment judged affordable by: –88% of pharmacy managers –50% of healthcare workers –55% of buyers Proportion of Healthcare Facilities with Community Pharmacy, Burkina Faso,

Findings (1): Patient Demand for Safe Injections between 1992 and 2001, According to Healthcare Workers

Findings (2): Origin of Injection Equipment Found in Pharmacies Trade markNumber of community pharmacies Proportion (%) * PentaFerte (Italy, official)4284% Others (Spain)510% Others (Germany)36% Data missing510% * Total exceeding 100% as some pharmacies carried more than one type

Rational Drug Use Indicators during the Months of June, Burkina Faso, % 10% 20% 30% 40% 50% 60% 1992 (n=5) 1995 (n=16) 1997 (n=28) 1998 (n=32) 2000 (n=41) Year Proportion of prescriptions Prescriptions with an antibiotic Prescriptions with an injection 30 Prescriptions reviewed in each facility

Reported Awareness Regarding Pathogens Transmitted through Unsafe Injections Burkina Faso, %10%20%30%40%50%60%70%80%90%100% HIV HBV HCV Proportion (%) Awareness in the population Awareness among providers

Impact of the National Drug Policy on Injection Practices in Burkina Faso: (1) Strengths Increased access to safe injection equipment No major adverse effects in terms of: Injection overuse Worsening of sharps waste management situation, as perceived by healthcare workers National drug policy may have contributed to: Decrease in the re-use of equipment in the absence of sterilization Consumer demand for safe equipment

Impact of the National Drug Policy on Injection Practices in Burkina Faso: (2) Weaknesses Unsafe practices in the area of: –Sharps waste collection –Sharps waste management Limited implementation of recommended prices Cost recovery as per Bamako initiative is the keystone of the whole system

Recommendations Address price control and profit margin issue Implement policies and plans for safe healthcare waste management Bundle auto-disable injection equipment and sharps boxes with vaccines Combine curative injection equipment orders to sharps boxes Include sharps boxes in the list of essential drugs Finance sharps boxes with cost recovery using syringes and needles sales

Healthcare Workers Perception Regarding Sharps Waste Management between 1992 and 2001 Improvement No change Worsening